Ask AI
ProCE Banner Activity

Medical Minute 3: Emerging Treatment for Anemia of CKD—HIF-PH Inhibitors

Slideset Download

A leading expert in CKD discusses emerging treatment for anemia of CKD, specifically with HIF-PH inhibitors.

Released: December 14, 2022

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Faculty Disclosure

Primary Author

Jay B. Wish, MD

Professor of Clinical Medicine
Indiana University School of Medicine
Chief Medical Officer for Outpatient Hemodialysis
Indian University Health
Indianapolis, Indiana

Jay Wish, MD: consultant/advisor/speaker: Akebia, Amgen, AstraZeneca, CSL Behring, FibroGen, Otsuka, Rockwell Medical, Vifor Pharma; independent contractor: GlaxoSmithKline.